Drug Shortage Report for TOBRAMYCIN INJECTION

Last updated on 2023-04-03 History
Report ID 162164
Drug Identification Number 02230640
Brand name TOBRAMYCIN INJECTION
Common or Proper name TOBRAMYCIN INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 30mL
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-02
Estimated end date 2023-03-31
Actual end date 2023-03-31
Shortage status Resolved
Updated date 2023-04-03
Company comments On backorder effective September 1, 2022 until March 31, 2023.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2023-04-03 French Compare
v18 2023-04-03 English Compare
v17 2023-02-24 French Compare
v16 2023-02-24 English Compare
v15 2022-12-15 French Compare
v14 2022-12-15 English Compare
v13 2022-12-04 French Compare
v12 2022-12-04 English Compare
v11 2022-08-24 French Compare
v10 2022-08-24 English Compare
v9 2022-08-24 French Compare
v8 2022-08-24 English Compare
v7 2022-08-08 French Compare
v6 2022-08-08 English Compare
v5 2022-08-04 French Compare
v4 2022-08-04 English Compare
v3 2022-06-08 French Compare
v2 2022-06-08 French Compare
v1 2022-06-08 English Compare

Showing 1 to 19 of 19